Date & Time:
Tuesday, May 24, 2016
6:30 pm - 7:00 pm Registration and Dinner
7:00 pm - 8:30 pm Program
Adenike Atanda, PharmD
PGY2 Ambulatory Care Pharmacy Resident
University of Illinois at Chicago
Chicago, Illinois
Veronica Fassio, PharmD
PGY2 Medication Use Safety Resident
VA Center for Medication Safety
Hines, Illinois
Katherine Gruenberg, PharmD
PGY1 Pharmacy Practice Resident
Northwestern Memorial Hospital
Chicago, Illinois
Dipale Patel, PharmD, MBA, BCPS
PGY2 Health-System Pharmacy Administration Resident
NorthShore University HealthSystem
Evanston, Illinois
Registration:
This program is free to ICHP members and UIC Alumni. You must register online in advance to attend this program. Register below. Members and alumni who do not attend and do not cancel within 48 hours of the program will be charged $10.00 to cover expenses. The charges will be on hold and processed after the meeting as appropriate. Members and alumni who register and do attend the meeting, will not be charged the fee. Please bring a copy of your registration verification form with you to the meeting. There is limited seating, so register early.
Learning Objectives for Pharmacists:1. Describe common characteristics of specialty medications.
2. Identify access barriers for specialty medications.
3. Discuss the prevalence and incidence of NSAID and opioid use in relation to the implementation of an opioid safety initiative.
4. Discuss the changes in NSAID and opioid use in relation to the implementation of an opioid safety initiative.
5. Estimate the risk of adverse events typically associated with NSAIDs among incident NSAID and opioid users.
6. Recognize the evidence of statin use in hospital-associated Clostridium difficile infection (CDI).
7. Define the Infectious Diseases Society of America (IDSA) guideline criteria and Zar criteria used to classify CDI severity.
8. Explain the importance for the creation of the diversion prevention and detection taskforce.
9. List the tasks assigned to the diversion prevention and detection taskforce.
Learning Objectives for Technicians:1. Describe common characteristics of specialty medications.
2. Identify access barriers for specialty medications.
3. Discuss the prevalence and incidence of NSAID and opioid use in relation to the implementation of an opioid safety initiative.
4. Discuss the changes in NSAID and opioid use in relation to the implementation of an opioid safety initiative.
5. Recognize the evidence of statin use in hospital-associated Clostridium difficile infection (CDI).
6. Define the Infectious Diseases Society of America (IDSA) guideline criteria and Zar criteria used to classify CDI severity.
7. Explain the importance for the creation of the diversion prevention and detection taskforce.
8. List the tasks assigned to the diversion prevention and detection taskforce.
Accreditation:
ACPE # 0121-0000-16-027-L04-P and 0121-0000-16-027-L04-T
1.5 Contact Hours (0.15 CEUs) Type of Activity: Knowledge-based
The Illinois Council of Health System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
To receive your CPE credit, you will need to complete the online evaluation forms and then your credit will automatically be reported to CPE Monitor. Information on accessing the online evaluation system will be provided at the meeting.
PTCB now requires CPhTs to earn only pharmacy technician-specific (‘T-specific’) credit to qualify for recertification. As of January 1, 2015, ALL CPE credit earned must be T-specific. In addition, PTCB will reduce the number of allowable CPE hours earned through inservice training from 10 to 5. Please advise all pharmacy technicians at your site of this change.
Target Audience: Health-System Pharmacists and Pharmacy Technicians
Faculty Disclosure:
It is the policy of ICHP to ensure balance, independence, objectivity, and scientific rigor in all of its education programs. In accordance with this policy, faculty must disclose to the participants any significant relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of these continuing pharmacy education programs. These disclosures will be available at the program.
